J&J Units Resolve Spat Over Razadyne-ER Patent
Three Johnson & Johnson units have resolved a dispute with a trio of generic-drug makers that they accused of infringing a patent covering the Alzheimer's treatment Razadyne-ER....To view the full article, register now.
Already a subscriber? Click here to view full article